BackTeva- Pharmaceutical Industries Overview
Teva- Pharmaceutical Industries Ltd. - ADR

Teva- Pharmaceutical Industries Target Price

Analysts' average 12-month price target for Teva- Pharmaceutical Industries is $46.

Get informed when a big investor buys or sells

+ Follow

Share Price

$39.53

Average Target Price

$45.8015.9% upside

5 analysts in the last 4 months

High: $50 | Low: $42

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-23OppenheimerLes Sulewski$5026.5% upsideOpen
2026-09-09Leerink Partners$4513.8% upsideOpen
2026-09-04UBSAshwani Verma$4821.4% upsideOpen
2026-08-12Barclays$426.2% upsideOpen
2026-07-28Piper SandlerDavid Amsellem$4411.3% upsideOpen
2026-05-06Barclays$401.2% upsideOpen
2026-04-30UBS$426.2% upsideOpen
2026-04-30Piper Sandler$426.2% upsideOpen
2026-03-04Piper SandlerDavid Amsellem$413.7% upsideOpen
2026-01-30BarclaysGlen Santangelo$383.9% downsideOpen
2026-01-29Scotiabank$401.2% upsideOpen
2026-01-07Truist Financial$368.9% downsideOpen
2026-01-06Jefferies$401.2% upsideOpen
2025-12-22Piper Sandler$401.2% upsideOpen
2025-12-18Goldman Sachs$3511.5% downsideOpen
2025-12-08Barclays$3511.5% downsideOpen
2025-12-04Scotiabank$3511.5% downsideOpen
2025-11-06Goldman SachsMatt Dellatorre$2829.2% downsideOpen
2024-12-18UBSAshwani Verma$2829.2% downsideOpen
2024-12-18BarclaysBalaji Prasad$2829.2% downsideOpen
2024-10-23BarclaysBalaji Prasad$2536.8% downsideOpen
2024-10-01Bank of America SecuritiesJason Gerberry$2244.3% downsideOpen
2024-09-03UBSAshwani Verma$2634.2% downsideOpen
2024-08-28Piper SandlerDavid Amsellem$2341.8% downsideOpen
2024-08-01BarclaysBalaji Prasad$2244.3% downsideOpen
2024-07-10Argus ResearchJasper Hellweg$2049.4% downsideOpen
2024-07-10UBSAshwani Verma$2439.3% downsideOpen
2024-06-05BarclaysBalaji Prasad$2146.9% downsideOpen
2024-05-23BarclaysBalaji Prasad$2049.4% downsideOpen
2024-05-13Piper SandlerDavid Amsellem$2049.4% downsideOpen
2024-02-12Piper SandlerDavid Amsellem$1951.9% downsideOpen
2024-01-23JefferiesGlen Santangelo$1464.6% downsideOpen
2022-11-14J.P. Morgan$1074.7% downsideOpen
2022-06-13UBSAshwani Verma$1074.7% downsideOpen
2022-05-04Piper Sandler$782.3% downsideOpen
2022-04-20BarclaysBalaji Prasad$1367.1% downsideOpen

Teva- Pharmaceutical Industries (TEVA) FAQ

Teva- Pharmaceutical Industries (TEVA) currently reports a target price of $46. Use the charts on this page to explore Teva- Pharmaceutical Industries's target price history and peer comparisons.

Analysts' average 12-month price target for Teva- Pharmaceutical Industries is $46, about 15.9% upside from the current share price of $39.53. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $46, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Teva- Pharmaceutical Industries, and consider following TEVA for alerts when major investors trade the stock.

Teva- Pharmaceutical Industries is classified in the Healthcare sector. On target price, it currently shows $46. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TEVA with unrelated industries.